GLPBio

GPR139

Read More about this category

GPR139 (G protein-coupled receptor 139) is a protein that in humans is encoded by the GPR139 gene. GPR139 is an orphan G-protein–coupled receptor expressed in the central nervous system.

The expression pattern of GPR139 has primarily been studied on the mRNA level and showed expression mainly in the central nervous system.

GPR139 is an orphan receptor identified from bioinformatics analysis of the human genome. GPR139 is thus a potential target for the treatment of Parkinson’s disease, obesity, eating disorders, and/or diabetes.

The GPR139 is expressed specifically in the brain in areas of relevance for motor control. GPR139 function and signal transduction pathways are elusive, and results in the literature are even contradictory. GPR139 agonists dose-dependently protect primary dopaminergic (DA) neurons against MPP+ toxicity.

Products Related to GPR139(4)

  • GC19209 structure
    GC19209JNJ-63533054
    CAS: 1802326-66-4
    Purity: >99.00%

    Le JNJ-63533054 est un agoniste puissant et sélectif de hGPR139 avec un EC50 = 16nM.

  • GC66431 structure
    GC66431NCRW0005-F05
    CAS: 342779-66-2
    Purity: >99.00%

    NCRW0005-F05 est un puissant agoniste du GPR139 avec une valeur IC50 de 0,21 μM. NCRW0005-F05 peut être utilisé pour la recherche sur le diabète, l'obésité et la maladie de Parkinson.

  • GC69400 structure
    GC69400LP-471756
    CAS: 413605-11-5
    Purity: >99.00%

    LP-471756 est un antagoniste efficace de GPR139 avec une valeur IC50 de 640 nM. LP-471756 inhibe la production de cAMP stimulée par LP-360924.

  • GC71095 structure
    GC71095GPR139 agonist-2
    CAS: 2983118-29-0
    Purity: >99.00%

    GPR139 agonist-2 (composé 20A) est un puissant agoniste du gpr139 avec une CE50 de 24,7 nm.